Latest Period
Q1 2026
Security Snapshot
Context Therapeutics Inc. - Common Stock (CNTX) Institutional Ownership
CUSIP: 21077P108
13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026
Institutions Reporting
59
Shares (Excl. Options)
74,175,436
Price
$2.62
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CNTX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 74,175,436
- Total 13F value
- $194,338,022
- Portfolio coverage rank
- 0%
- Share change
- +8,978,356
- Value change
- +$28,627,264
- Number of holders
- 59
- Shares outstanding
- 91,741,639
- SEC-reported price per share
- $2.39
- Insider filing price
- $2.39
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CNTX - Context Therapeutics Inc. - Common Stock is tracked under CUSIP 21077P108.
- 59 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 42 to 59 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $95,840,638 to $194,338,022.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 59 institutions filings for Q1 2026.
Security key
21077P108
Latest holder period
Q1 2026
13F holders
59
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
CNTX full holder history
Context Therapeutics Inc. SEC filings
Context Therapeutics Inc. company facts
Context Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 21077P108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
CNTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 12% | -30% | $15,698,705 | -$5,918,942 | 10,679,391 | -27% | MPM BioImpact LLC | 31 Dec 2025 |
| Avidity Partners Management LP | 8.7% | -12% | $21,753,357 | -$2,352,163 | 8,302,808 | -9.8% | Avidity Partners Management LP | 31 Mar 2026 |
| Deep Track Capital, LP | 8.3% | $7,419,355 | 7,419,355 | Deep Track Capital, LP | 31 Mar 2025 | |||
| Soleus Capital Master Fund, L.P. | 7.6% | +48% | $18,243,429 | +$5,729,267 | 6,963,141 | +46% | Soleus Capital Master Fund, L.P. | 31 Mar 2026 |
| Octagon Capital Advisors LP | 5.7% | $13,755,000 | 5,250,000 | Octagon Capital Advisors LP | 31 Mar 2026 | |||
| Blue Owl Capital Holdings LP | 5.5% | -37% | $13,333,219 | -$3,324,552 | 5,089,015 | -20% | Blue Owl Capital Holdings LP | 31 Mar 2026 |
| FRANKLIN RESOURCES INC | 4.5% | -16% | $4,003,380 | 4,003,380 | 0% | Franklin Resources, Inc. | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC | 2.4% | -53% | $5,864,860 | -$6,406,463 | 2,238,496 | -52% | Great Point Partners, LLC | 31 Mar 2026 |
| Lehr Martin A. | 2.1% | $1,595,742 | 1,595,742 | Martin Lehr | 31 Dec 2024 |
As of 31 Mar 2026, 59 institutional investors reported holding 74,175,436 shares of Context Therapeutics Inc. - Common Stock (CNTX). This represents 81% of the company’s total 91,741,639 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
79%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 12% | 10,679,391 | 0% | 2.2% | $27,980,004 |
| Deep Track Capital, LP | 8.1% | 7,419,355 | 0% | 0.4% | $19,438,710 |
| Nextech Invest, Ltd. | 8.1% | 7,419,355 | 0% | 1.4% | $19,438,710 |
| Soleus Capital Management, L.P. | 7.6% | 6,963,141 | 0.74% | $18,243,429 | |
| Octagon Capital Advisors LP | 5.7% | 5,250,000 | 1.5% | $13,755,000 | |
| Blue Owl Capital Holdings LP | 5.5% | 5,089,015 | -32% | 3.6% | $13,333,219 |
| Avidity Partners Management LP | 5.4% | 4,998,267 | -9.2% | 2.6% | $13,095,460 |
| FRANKLIN RESOURCES INC | 4.1% | 3,803,338 | -5% | 0% | $9,964,746 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 3,431,953 | 0% | 0% | $8,991,717 |
| MARSHALL WACE, LLP | 3.2% | 2,948,441 | +14% | 0.01% | $7,724,916 |
| TCG Crossover Management, LLC | 2.9% | 2,682,696 | 0.2% | $7,028,664 | |
| GREAT POINT PARTNERS LLC | 2.4% | 2,238,496 | -52% | 1.4% | $5,864,860 |
| MILLENNIUM MANAGEMENT LLC | 1.6% | 1,424,374 | -45% | 0% | $3,731,860 |
| Squadron Capital Management LLC | 1.2% | 1,100,000 | 1.2% | $2,882,000 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.2% | 1,093,894 | 0% | $2,866,002 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1% | 1,000,000 | 0% | $2,620,000 | |
| Sio Capital Management, LLC | 1% | 917,922 | -32% | 0.35% | $2,404,956 |
| BlackRock, Inc. | 0.92% | 846,696 | -0.16% | 0% | $2,218,344 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.66% | 603,767 | -0.77% | 0% | $1,582,701 |
| Cormorant Asset Management, LP | 0.58% | 529,550 | 0.07% | $1,387,421 | |
| JANE STREET GROUP, LLC | 0.48% | 436,931 | 0% | $1,144,760 | |
| ADAR1 Capital Management, LLC | 0.38% | 351,094 | 0% | 0.06% | $919,866 |
| VANGUARD FIDUCIARY TRUST CO | 0.37% | 341,344 | 0% | 0% | $894,321 |
| GOLDMAN SACHS GROUP INC | 0.31% | 287,299 | 0% | $752,723 | |
| Woodline Partners LP | 0.27% | 250,088 | 0% | $655,231 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
18
Latest
Q1 2026
Rows shown
1-18 of 18
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 74,175,436 | $194,338,022 | +$28,627,264 | $2.62 | 59 |
| 2025 Q4 | 65,197,080 | $95,840,638 | -$5,288,639 | $1.47 | 42 |
| 2025 Q3 | 68,966,266 | $66,815,968 | +$689,909 | $0.97 | 37 |
| 2025 Q2 | 68,619,580 | $44,959,003 | -$1,721,044 | $0.66 | 39 |
| 2025 Q1 | 71,405,968 | $43,712,940 | -$1,099,517 | $0.61 | 42 |
| 2024 Q4 | 72,797,034 | $76,436,064 | +$15,827,475 | $1.05 | 52 |
| 2024 Q3 | 56,682,696 | $111,154,599 | -$854,175 | $1.96 | 42 |
| 2024 Q2 | 57,034,586 | $114,325,460 | +$107,182,399 | $2.00 | 34 |
| 2024 Q1 | 3,935,132 | $5,430,813 | +$524,452 | $1.38 | 25 |
| 2023 Q4 | 3,558,639 | $4,020,714 | +$1,102,318 | $1.13 | 24 |
| 2023 Q3 | 2,578,656 | $3,893,359 | +$507,040 | $1.51 | 23 |
| 2023 Q2 | 2,239,166 | $3,582,021 | +$1,631,639 | $1.60 | 22 |
| 2023 Q1 | 1,276,355 | $717,889 | -$1,585,759 | $0.56 | 20 |
| 2022 Q4 | 3,883,345 | $2,545,096 | -$383,818 | $0.65 | 23 |
| 2022 Q3 | 4,130,839 | $4,587,000 | +$1,461,710 | $1.11 | 21 |
| 2022 Q2 | 2,747,803 | $5,761,000 | -$388,653 | $2.12 | 17 |
| 2022 Q1 | 2,904,420 | $6,302,000 | -$2,229,327 | $2.17 | 12 |
| 2021 Q4 | 3,549,370 | $9,441,000 | +$8,486,000 | $2.66 | 16 |